Pilot Study of Growth Hormon to Treat SMA Typ II and III

NCT00533221 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Muscular Atrophy, Spinal

Interventions

DRUG: somatotropin
DRUG: Placebo

Sponsor

University Hospital Freiburg

Collaborators

[object Object]